Purpose: The aim of this retrospective study was to estimate risk organ doses and to estimate radiation risks during the imaging work-up and treatment for aneurismal subarachnoid hemorrhage, SAH. Methods: The imaging procedures comprised computed tomography and digital subtraction angiography studies done for diagnosis or endovascular interventional procedures in 50 consecutive patients. Equivalent organ doses H T to skin, brain, eye lens, salivary glands, thyroid and oral mucosa were measured using thermo-luminescence dosimeters in an anthropomorphic head phantom. PACS and RIS records were analyzed and the frequency of each imaging procedure was recorded as well as the registered individual kerma-length product, P KL , and the kerma-area product, P KA . The doses were finally computed by multiplying the recorded P KL and P KA values by the conversion coefficients H T /P KL and H T /P KA from the head phantom. Results: The mean fluoroscopy time, P KL and P KA were 38 min, 7269 mGy cm and 286 Gy cm 2 , respectively. The estimated mean equivalent doses were as follows: skin 2.51 Sv, brain 0.92 Sv, eye lens 0.43 Sv, and salivary glands 0.23 Sv. Maximum organ doses were 2.3 -3.5 times higher than the mean. Interventional procedures contributed 66% to skin dose, 55% to brain dose and 25% to eye lens dose. Of the patients that had an estimated skin dose exceeding 6 Sv, only one patient developed temporary epilation.
Conclusion:The risk for radiation-induced cancer for SAH patients is low (2-3 cases per 1000 patients, of which 90% are expected to be of benign type) compared with the risk of tissue reactions on the head such as skin erythema and epilation (1 temporary epilation per 50 patients).